Alterity Therapeutics Limited (ATH.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.6 Million | -20.03 Million | -12.33 Million | -17.33 Million | -9.43 Million | -13.95 Million |
| Net Income | -19.12 Million | -13.8 Million | -12.84 Million | -15.3 Million | -10.05 Million | -12.33 Million |
| Depreciation & Amortization | 147.52 Thousand | 102.26 Thousand | 54.21 Thousand | 75.36 Thousand | 112.42 Thousand | 29.69 Thousand |
| Deferred income taxes | - | 2.99 Million | -1.05 Million | 2.33 Million | -250.96 Thousand | -493.01 Thousand |
| Stock-based compensation | 881.95 Thousand | 966.57 Thousand | 1.5 Million | 1.88 Million | -12.01 Thousand | 89.13 Thousand |
| Change in working capital | 5.74 Million | -3.94 Million | -447.68 Thousand | -4.21 Million | 791.12 Thousand | -1.33 Million |
| Other non-cash items | 6.66 Million | -6.33 Million | 455.57 Thousand | -2.09 Million | -12.01 Thousand | 89.13 Thousand |
| Investing Cash Flow | -5722.00 | -36.46 Thousand | -89.14 Thousand | -10.47 Thousand | -16.74 Thousand | -7022.00 |
| Investments in PPE | -5722.00 | -7311.00 | -89.14 Thousand | -10.47 Thousand | -16.74 Thousand | -7022.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -29.15 Thousand | - | - | - | - |
| Financing Cash Flow | 9.21 Million | 124.34 Thousand | 16.3 Million | 36.68 Million | 3.98 Million | 12.72 Million |
| Debt repayment | -10.37 Thousand | -59.92 Thousand | -34.51 Thousand | -58.28 Thousand | -89.24 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9.22 Million | 184.26 Thousand | 16.33 Million | 36.74 Million | 4.36 Million | 13.08 Million |
| Other Financing Activities | -918.02 Thousand | -132.41 Thousand | -836.96 Thousand | -2.49 Million | -292.76 Thousand | -362.32 Thousand |
| Accounts receivables | 4.62 Million | -3.94 Million | -447.68 Thousand | -4.21 Million | 4.76 Million | -1.67 Million |
| Accounts payables | 1.1 Million | -1.56 Million | 2.6 Million | 432.9 Thousand | -648.57 Thousand | 662.92 Thousand |
| Inventory | - | 2.45 Million | -2.21 Million | 191.12 Thousand | 648.57 Thousand | -662.92 Thousand |
| Other working capital | -218 Thousand | -889.52 Thousand | -393.29 Thousand | -624.03 Thousand | -3.97 Million | 345.14 Thousand |
| Cash at beginning of period | 15.77 Million | 34.8 Million | 28.11 Million | 9.19 Million | 14.39 Million | 15.23 Million |
| Cash at end of period | 12.63 Million | 15.77 Million | 34.8 Million | 28.11 Million | 9.19 Million | 14.39 Million |
| Capital Expenditure | -5722.00 | -7311.00 | -89.14 Thousand | -10.47 Thousand | -16.74 Thousand | -7022.00 |
| Effect of forex changes on cash | 260.35 Thousand | 914.94 Thousand | 2.81 Million | -426.78 Thousand | 262.97 Thousand | 403.87 Thousand |
| Net cash flow / Change in cash | -3.13 Million | -19.03 Million | 6.69 Million | 18.91 Million | -5.2 Million | -835.65 Thousand |
| Free Cash Flow | -12.61 Million | -20.04 Million | -12.42 Million | -17.34 Million | -9.44 Million | -13.96 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -19.12 Million | -12.61 Million | - | -6.5 Million | - | -13.8 Million |
| Depreciation & Amortization | 147.52 Thousand | 73.61 Thousand | - | 73.91 Thousand | - | 102.26 Thousand |
| Deferred income taxes | - | - | - | -312.28 Thousand | - | 2.99 Million |
| Stock-based compensation | - | 569.66 Thousand | - | 312.28 Thousand | - | 966.57 Thousand |
| Change in working capital | - | 3.13 Million | - | 1.62 Million | - | -3.94 Million |
| Other non-cash items | 6.66 Million | 4.57 Million | - | -51.54 Thousand | - | -6.33 Million |
| Investing Cash Flow | -5722.00 | -722.00 | - | -1000.00 | -4000.00 | -36.46 Thousand |
| Investments in PPE | -5722.00 | 278.00 | - | -2000.00 | -4000.00 | -7311.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1000.00 | - | 1000.00 | - | -29.15 Thousand |
| Financing Cash Flow | 9.21 Million | 8.16 Million | 8.25 Million | 970 Thousand | -17 Thousand | 124.34 Thousand |
| Debt repayment | - | -10.37 Thousand | - | -54.78 Thousand | - | -59.92 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 9.22 Million | 8.12 Million | 8.92 Million | 1.12 Million | - | 184.26 Thousand |
| Other Financing Activities | - | -72.02 Thousand | -673 Thousand | -156 Thousand | -17 Thousand | -132.41 Thousand |
| Accounts receivables | - | 1.94 Million | - | 2.68 Million | - | -3.94 Million |
| Accounts payables | - | 989.3 Thousand | - | 112.93 Thousand | - | -1.56 Million |
| Inventory | - | - | - | - | - | 2.45 Million |
| Other working capital | - | 1.19 Million | - | -1.17 Million | - | -889.52 Thousand |
| Cash at beginning of period | 15.77 Million | 12.32 Million | 12.32 Million | 16.7 Million | 15.77 Million | 34.8 Million |
| Cash at end of period | 12.63 Million | 12.63 Million | 18.3 Million | 12.32 Million | 16.7 Million | 15.77 Million |
| Capital Expenditure | -5722.00 | 278.00 | - | -2000.00 | -4000.00 | -7311.00 |
| Effect of forex changes on cash | - | 39.35 Thousand | 307 Thousand | -495 Thousand | 408 Thousand | 914.94 Thousand |
| Net cash flow / Change in cash | -3.13 Million | 318.45 Thousand | 5.98 Million | -4.38 Million | 936 Thousand | -19.03 Million |
| Free Cash Flow | -12.61 Million | -8.11 Million | - | -4.86 Million | 545 Thousand | -20.04 Million |
8920
HI
ZEPP
KRX
BLAND-R
WAAREERTL